The U.S. Department of Justice (DOJ) and other government enforcers announced a number of key settlements in the life sciences industry in October – December 2019. These settlements include:
| LIFE SCIENCES INDIVIDUALS/ ENTITIES | SETTLEMENT DATE | RESOLUTION | KEY AREAS OF ENFORCEMENT |
| Pharmaceutical company | Dec. 3, 2019 | $3 million Deferred prosecution agreement Restitution |
|
| Charitable foundation | Nov. 20, 2019 | $4 million Three year integrity agreement |
|
|
Medical device company |
Nov. 7, 2019 | $5.99 million |
|
| Pharmaceutical supplier | Nov. 7, 2019 | $22.05 million |
|
| Two charitable foundations | Oct. 25, 2019 | $4 million $2 million Three-year integrity agreements |
|
|
Genetic testing company |
Oct. 9, 2019 | $42.6 million Exclusion |
|
These settlements demonstrate the continued importance for life sciences companies to monitor industry developments and determine ways in which to improve their corporate compliance programs.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.